Cargando…

In utero therapy for congenital disorders using amniotic fluid stem cells

Congenital diseases are responsible for over a third of all pediatric hospital admissions. Advances in prenatal screening and molecular diagnosis have allowed the detection of many life-threatening genetic diseases early in gestation. In utero transplantation (IUT) with stem cells could cure affecte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramachandra, Durrgah L., Shaw, Steven S. W., Shangaris, Panicos, Loukogeorgakis, Stavros, Guillot, Pascale V., Coppi, Paolo De, David, Anna L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271591/ https://www.ncbi.nlm.nih.gov/pubmed/25566071 http://dx.doi.org/10.3389/fphar.2014.00270

Ejemplares similares

Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2015)

Long-Term Hematopoietic Engraftment of Congenic Amniotic Fluid Stem Cells After in Utero Intraperitoneal Transplantation to Immune Competent Mice
por: Shangaris, Panicos, et al.
Publicado: (2018)

In Utero Transplantation of Expanded Autologous Amniotic Fluid Stem Cells Results in Long‐Term Hematopoietic Engraftment
por: Loukogeorgakis, Stavros P., et al.
Publicado: (2019)

Isolation of esophageal stem cells with potential for therapy
por: Maghsoudlou, Panagiotis, et al.
Publicado: (2014)

In Utero Gene Therapy (IUGT) Using GLOBE Lentiviral Vector Phenotypically Corrects the Heterozygous Humanised Mouse Model and Its Progress Can Be Monitored Using MRI Techniques
por: Shangaris, Panicos, et al.
Publicado: (2019)

Publisher Correction: In Utero Gene Therapy (IUGT) Using GLOBE Lentiviral Vector Phenotypically Corrects the Heterozygous Humanised Mouse Model and Its Progress Can Be Monitored Using MRI Techniques
por: Shangaris, Panicos, et al.
Publicado: (2019)

TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine production
por: Hau, Kwan-Leong, et al.
Publicado: (2017)

Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A
por: Vlahova, Filipa, et al.
Publicado: (2019)

Publisher Correction: Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A
por: Vlahova, Filipa, et al.
Publicado: (2020)

Neuroprotection of the hypoxic-ischemic mouse brain by human CD117(+)CD90(+)CD105(+) amniotic fluid stem cells
por: Corcelli, Michelangelo, et al.
Publicado: (2018)

In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System
por: Cortabarria, Alba Saenz de Villaverde, et al.
Publicado: (2021)

Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders
por: Shi, Chunyu, et al.
Publicado: (2022)

Congenital diaphragmatic hernia subtypes: Comparing birth prevalence, occurrence by maternal age, and mortality in a national birth cohort
por: Peppa, Maria, et al.
Publicado: (2022)

Unilateral clubfoot with amniotic band in-utero
por: Patwa, Prerna Anup, et al.
Publicado: (2021)

Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT)
por: Loewendorf, Andrea I., et al.
Publicado: (2015)

Counteracting bone fragility with human amniotic mesenchymal stem cells
por: Ranzoni, Anna M., et al.
Publicado: (2016)

Human Amniotic Fluid Mesenchymal Stem Cells Improve Ovarian Function During Physiological Aging by Resisting DNA Damage
por: Huang, Boxian, et al.
Publicado: (2020)

Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia
por: Schiavo, Andrea Alex, et al.
Publicado: (2015)

Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach
por: Moschidou, Dafni, et al.
Publicado: (2012)

Prenatal transplantation of human amniotic fluid stem cell could improve clinical outcome of type III spinal muscular atrophy in mice
por: Shaw, Steven W., et al.
Publicado: (2021)

Consensus statement from the first international conference for in utero stem cell transplantation and gene therapy
por: MacKenzie, Tippi C., et al.
Publicado: (2015)

Optimization of Liver Decellularization Maintains Extracellular Matrix Micro-Architecture and Composition Predisposing to Effective Cell Seeding
por: Maghsoudlou, Panagiotis, et al.
Publicado: (2016)

First steps to define murine amniotic fluid stem cell microenvironment
por: Bertin, E., et al.
Publicado: (2016)

Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid
por: Collado, Maria Carmen, et al.
Publicado: (2016)

Fetal microchimerism and beyond: a new player in regenerative medicine
por: Shangaris, Panicos, et al.
Publicado: (2023)

The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time
por: Rahman, Md Shaifur, et al.
Publicado: (2018)

Characterization of Torquetenovirus in amniotic fluid at the time of in utero fetal surgery: correlation with early premature delivery and respiratory distress
por: Tozetto-Mendoza, Tania Regina, et al.
Publicado: (2023)

Development of a Rat Model of Intra-Amniotic Inflammation via Ultrasound-Guided Administration of a Triggering Agent in the Gestational Sac to Enable Analysis of Individual Amniotic Fluid Samples
por: Stranik, Jaroslav, et al.
Publicado: (2022)

In utero hematopoietic cell transplantation for hemoglobinopathies
por: Derderian, S. Christopher, et al.
Publicado: (2015)

Amniotic Fluid and Amniotic Membrane Stem Cells: Marker Discovery
por: Roubelakis, Maria G., et al.
Publicado: (2012)

In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion
por: Abe, Yushi, et al.
Publicado: (2019)

Thoracoscopic vs open repair of congenital diaphragmatic hernia after extracorporeal membrane oxygenation: a comparison of intra-operative data
por: Budzanowski, Annita, et al.
Publicado: (2023)

A Decellularization Methodology for the Production of a Natural Acellular Intestinal Matrix
por: Maghsoudlou, Panagiotis, et al.
Publicado: (2013)

Cell-based interventions in utero: time to reconsider
por: King, Nancy M. P., et al.
Publicado: (2014)

Hemophilia A: an ideal disease to correct in utero
por: Porada, Christopher D., et al.
Publicado: (2014)

Treatment of necrotizing enterocolitis by conditioned medium derived from human amniotic fluid stem cells
por: O’Connell, Joshua S., et al.
Publicado: (2021)

In Utero Cell Treatment of Hemophilia A Mice via Human Amniotic Fluid Mesenchymal Stromal Cell Engraftment
por: Kao, Yung-Tsung, et al.
Publicado: (2023)

Amniotic fluid biomarkers predict the severity of congenital cytomegalovirus infection
por: Vorontsov, Olesya, et al.
Publicado: (2022)

Cytokine Profiling of Amniotic Fluid from Congenital Cytomegalovirus Infection
por: Bourgon, Nicolas, et al.
Publicado: (2022)

Amniotic Fluid Stem Cells: Future Perspectives
por: Rosner, Margit, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ldk48c4d611h5s9qklm4f4nbav